Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Chikara Aizawa

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Procedures

Living Beings

Disorders

Anatomy

Nasal Mucosa

Physiology

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Watanabe Izumi; Hagiwara Yukari; Kadowaki Shin-etsu; Yoshikawa Tomoki; Komase Katsuhiro; Aizawa Chikara; Kiyono Hiroshi; Takeda Yoshifumi; McGhee Jerry R; Chiba Joe; Sata Tetsutaro; Kurata Takeshi; Tamura Shin-ichi
Characterization of protective immune responses induced by nasal influenza vaccine containing mutant cholera toxin as a safe adjuvant (CT112K).
Asahi Yasuko; Yoshikawa Tomoki; Watanabe Izumi; Iwasaki Takuya; Hasegawa Hideki; Sato Yuko; Shimada Shin-ichiro; Nanno Masanobu; Matsuoka Yoshiaki; Ohwaki Makoto; Iwakura Yoichiro; Suzuki Yujiro; Aizawa Chikara; Sata Tetutaro; Kurata Takeshi; Tamura Shin-ichi
Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines.
Asanuma H; Hirokawa K; Uchiyama M; Suzuki Y; Aizawa C; Kurata T; Sata T; Tamura S
Immune responses and protection in different strains of aged mice immunized intranasally with an adjuvant-combined influenza vaccine.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Chikara Aizawa (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2002: Watanabe Izumi; Hagiwara Yukari; Kadowaki Shin-etsu; Yoshikawa Tomoki; Komase Katsuhiro; Aizawa Chikara; Kiyono Hiroshi; Takeda Yoshifumi; McGhee Jerry R; Chiba Joe; Sata Tetsutaro; Kurata Takeshi; Tamura Shin-ichi
Characterization of protective immune responses induced by nasal influenza vaccine containing mutant cholera toxin as a safe adjuvant (CT112K).
Vaccine 2002;20(29-30):3443-55.
2002: Asahi Yasuko; Yoshikawa Tomoki; Watanabe Izumi; Iwasaki Takuya; Hasegawa Hideki; Sato Yuko; Shimada Shin-ichiro; Nanno Masanobu; Matsuoka Yoshiaki; Ohwaki Makoto; Iwakura Yoichiro; Suzuki Yujiro; Aizawa Chikara; Sata Tetutaro; Kurata Takeshi; Tamura Shin-ichi
Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(6):2930-8.
2001: Asanuma H; Hirokawa K; Uchiyama M; Suzuki Y; Aizawa C; Kurata T; Sata T; Tamura S
Immune responses and protection in different strains of aged mice immunized intranasally with an adjuvant-combined influenza vaccine.
Vaccine 2001;19(28-29):3981-9.
2001: Hagiwar Y; Tsuji T; Iwasaki T; Kadowaki S; Asanuma H; Chen Z; Komase K; Suzuki Y; Aizawa C; Kurata T; Tamura S
Effectiveness and safety of mutant Escherichia coli heat-labile enterotoxin (LT H44A) as an adjuvant for nasal influenza vaccine.
Vaccine 2001;19(15-16):2071-9.
2001: Hagiwara Y; Iwasaki T; Asanuma H; Sato Y; Sata T; Aizawa C; Kurata T; Tamura S
Effects of intranasal administration of cholera toxin (or Escherichia coli heat-labile enterotoxin) B subunits supplemented with a trace amount of the holotoxin on the brain.
Vaccine 2001;19(13-14):1652-60.
2000: Kadowaki S; Chen Z; Asanuma H; Aizawa C; Kurata T; Tamura S
Protection against influenza virus infection in mice immunized by administration of hemagglutinin-expressing DNAs with electroporation.
Vaccine 2000;18(25):2779-88.
1999: Chen Z; Yoshikawa T; Kadowaki S; Hagiwara Y; Matsuo K; Asanuma H; Aizawa C; Kurata T; Tamura S
Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein.
The Journal of general virology 1999;80 ( Pt 10)():2559-64.
1999: Hagiwara Y; Komase K; Chen Z; Matsuo K; Suzuki Y; Aizawa C; Kurata T; Tamura S
Mutants of cholera toxin as an effective and safe adjuvant for nasal influenza vaccine.
Vaccine 1999;17(22):2918-26.
1999: Chen Z; Matsuo K; Asanuma H; Takahashi H; Iwasaki T; Suzuki Y; Aizawa C; Kurata T; Tamura S
Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs.
Vaccine 1999;17(7-8):653-9.
1998: Chen Z; Sahashi Y; Matsuo K; Asanuma H; Takahashi H; Iwasaki T; Suzuki Y; Aizawa C; Kurata T; Tamura S
Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza.
Vaccine 1998;16(16):1544-9.
1998: Asanuma H; Aizawa C; Kurata T; Tamura S
IgA antibody-forming cell responses in the nasal-associated lymphoid tissue of mice vaccinated by intranasal, intravenous and/or subcutaneous administration.
Vaccine 1998;16(13):1257-62.
1998: Tamura S; Iwasaki T; Thompson A H; Asanuma H; Chen Z; Suzuki Y; Aizawa C; Kurata T
Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infection.
The Journal of general virology 1998;79 ( Pt 2)():291-9.
1998: Komase K; Tamura S; Matsuo K; Watanabe K; Hattori N; Odaka A; Suzuki Y; Kurata T; Aizawa C
Mutants of Escherichia coli heat-labile enterotoxin as an adjuvant for nasal influenza vaccine.
Vaccine 1998;16(2-3):248-54.
1997: Tamura S; Yajima A; Hatori E; Tamura S; Asanuma H; Suzuki Y; Aizawa C; Kurata T
Effects of frequent intranasal administration of adjuvant-combined influenza vaccine on the protection against virus infection.
Vaccine 1997;15(16):1784-90.
1997: Asanuma H; Thompson A H; Iwasaki T; Sato Y; Inaba Y; Aizawa C; Kurata T; Tamura S
Isolation and characterization of mouse nasal-associated lymphoid tissue.
Journal of immunological methods 1997;202(2):123-31.
1997: Tamura S; Hatori E; Tsuruhara T; Aizawa C; Kurata T
Suppression of delayed-type hypersensitivity and IgE antibody responses to ovalbumin by intranasal administration of Escherichia coli heat-labile enterotoxin B subunit-conjugated ovalbumin.
Vaccine 1997;15(2):225-9.
1996: Tamura S; Miyata K; Matsuo K; Asanuma H; Takahashi H; Nakajima K; Suzuki Y; Aizawa C; Kurata T
Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(10):3892-900.
1995: Asanuma H; Inaba Y; Aizawa C; Kurata T; Tamura S
Characterization of mouse nasal lymphocytes isolated by enzymatic extraction with collagenase.
Journal of immunological methods 1995;187(1):41-51.
1995: Tamura S; Ishihara K; Miyata K; Aizawa C; Kurata T
Mechanism of enhancement of the immune responses to influenza vaccine with cholera toxin B subunit and a trace amount of holotoxin.
Vaccine 1995;13(4):339-41.
1995: Asanuma H; Koide F; Suzuki Y; Nagamine T; Aizawa C; Kurata T; Tamura S
Cross-protection against influenza virus infection in mice vaccinated by combined nasal/subcutaneous administration.
Vaccine 1995;13(1):3-5.
1994: Tamura S; Shoji Y; Hasiguchi K; Aizawa C; Kurata T
Effects of cholera toxin adjuvant on IgE antibody response to orally or nasally administered ovalbumin.
Vaccine 1994;12(13):1238-40.
1994: Tamura S; Asanuma H; Ito Y; Yoshizawa K; Nagamine T; Aizawa C; Kurata T
Formulation of inactivated influenza vaccines for providing effective cross-protection by intranasal vaccination in mice.
Vaccine 1994;12(4):310-6.
1992: Tamura S; Ito Y; Asanuma H; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T
Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit.
Journal of immunology (Baltimore, Md. : 1950) 1992;149(3):981-8.
1992: Tamura S I; Asanuma H; Ito Y; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T; Oya A
Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine.
European journal of immunology 1992;22(2):477-81.
1992: Gizurarson S; Tamura S; Aizawa C; Kurata T
Stimulation of the transepithelial flux of influenza HA vaccine by cholera toxin B subunit.
Vaccine 1992;10(2):101-6.
1991: Tamura S; Funato H; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T
Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules.
European journal of immunology 1991;21(6):1337-44.
1991: Hirabayashi Y; Tamura S I; Suzuki Y; Nagamine T; Aizawa C; Shimada K; Kurata T
H-2-unrestricted adjuvant effect of cholera toxin B subunit on murine antibody responses to influenza virus haemagglutinin.
Immunology 1991;72(3):329-35.
1990: Kikuta K; Hirabayashi Y; Nagamine T; Aizawa C; Ueno Y; Oya A; Kurata T; Tamura S
Cross-protection against influenza B type virus infection by intranasal inoculation of the HA vaccines combined with cholera toxin B subunit.
Vaccine 1990;8(6):595-9.
1990: Tamura S; Funato H; Hirabayashi Y; Kikuta K; Suzuki Y; Nagamine T; Aizawa C; Nakagawa M; Kurata T
Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza.
Vaccine 1990;8(5):479-85.
1990: Hirabayashi Y; Kurata H; Funato H; Nagamine T; Aizawa C; Tamura S; Shimada K; Kurata T
Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination.
Vaccine 1990;8(3):243-8.
1990: Kikuta K; Kurata H; Nagamine T; Aizawa C; Ueno Y; Kurata T; Tamura S
Enhancement of DTH response by cholera toxin B subunit inoculated intranasally together with influenza HA vaccine.
Microbiology and immunology 1990;34(3):337-46.
1989: Tamura S; Funato H; Nagamine T; Aizawa C; Kurata T
Effectiveness of cholera toxin B subunit as an adjuvant for nasal influenza vaccination despite pre-existing immunity to CTB.
Vaccine 1989;7(6):503-5.
1989: Tamura S; Kurata H; Funato H; Nagamine T; Aizawa C; Kurata T
Protection against influenza virus infection by a two-dose regimen of nasal vaccination using vaccines combined with cholera toxin B subunit.
Vaccine 1989;7(4):314-20.
1989: Tamura S I; Samegai Y; Kurata H; Kikuta K; Nagamine T; Aizawa C; Kurata T
Enhancement of protective antibody responses by cholera toxin B subunit inoculated intranasally with influenza vaccine.
Vaccine 1989;7(3):257-62.
1988: Tamura S; Samegai Y; Kurata H; Nagamine T; Aizawa C; Kurata T
Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit.
Vaccine 1988;6(5):409-13.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Chikara Aizawa

Research Profile (preview)

Chemicals & Drugs

Procedures

Living Beings

Disorders

Anatomy

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Chikara Aizawa (preview)

All Publications